09.06.2020
- Pierre-Alain Ruffieux has been appointed CEO of Swiss CDMO Lonza, with effect from 1 November 2020. The new chief executive will succeed Marc Funk, who led the company from March...
22.05.2020
- Roche has signed a worldwide option and license agreement with Vividion Therapeutics, gaining access to the latter’s proteomics screening platform and proprietary small molecule...
15.04.2020
- Swiss drugmaker Roche has entered into a strategic collaboration and license agreement with US biopharma Arrakis Therapeutics for the discovery of RNA-targeted small molecule (rSM)...
21.02.2020
- Swiss pharma giant Roche has closed its acquisition of US clinical-stage biotech Promedior. Roche snapped up the Lexington, Massachusetts-based firm for an upfront cash payment of...
06.12.2019
- The chemical, pharmaceutical and life sciences industries in Switzerland — organized in the Scienceindustries trade association — account for 45% of total exports with around 70...
25.07.2019
- Under an exclusive deal with Roche, French drugmaker Sanofi has secured non-prescription rights to the Swiss pharmaceutical giant’s now off-patent influenza drug Tamiflu in the US...
28.02.2019
- Swiss drugs giant Roche has agreed to pay $4.3 billion for Spark Therapeutics, marking the latest purchase of a biotech company by big pharma. The deal gives Roche the first US...
11.12.2018
- Gilead Sciences has nabbed Daniel O’Day, head of Roche’s pharma business, as its new chief executive to replace current CEO John Milligan, with effective from March 2019. Both...
